MEDICINOVA, INC. Accounts Payable
MEDICINOVA, INC. (MNOV) had Accounts Payable of $950.50 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable, Current $950.50K.
- 2026-03-31: Accounts Payable, Current $852.37K.
- 2025-12-31: Accounts Payable, Current $625.00K.
- 2025-09-30: Accounts Payable, Current $745.96K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $950.50K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $852.37K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $625.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $745.96K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $569.45K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $718.89K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $1.10M 10-K · filed 2026-03-10 |
| 2024-09-30 | $708.20K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $667.70K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $804.76K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.00M 10-K · filed 2025-02-19 |
| 2023-09-30 | $736.90K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $548.22K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $585.07K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $424.65K 10-K · filed 2024-02-15 |
| 2022-09-30 | $552.72K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $642.63K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $665.25K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $402.74K 10-K/A · filed 2023-03-28 |
| 2021-09-30 | $642.42K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $607.15K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $428.15K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $616.63K 10-K · filed 2022-02-16 |
| 2020-09-30 | $376.27K 10-Q · filed 2020-10-26 |
| 2020-06-30 | $576.51K 10-Q · filed 2020-07-28 |
| 2020-03-31 | $377.50K 10-Q · filed 2020-04-23 |
| 2019-12-31 | $451.33K 10-K · filed 2021-02-19 |
| 2019-09-30 | $230.38K 10-Q · filed 2019-10-24 |
| 2019-06-30 | $328.16K 10-Q · filed 2019-07-25 |
| 2019-03-31 | $254.11K 10-Q · filed 2019-04-25 |
| 2018-12-31 | $616.75K 10-K · filed 2020-02-13 |
| 2018-09-30 | $608.28K 10-Q · filed 2018-10-25 |
| 2018-06-30 | $351.87K 10-Q · filed 2018-07-23 |
| 2018-03-31 | $361.41K 10-Q · filed 2018-04-25 |
| 2017-12-31 | $1.52M 10-K · filed 2019-02-13 |
| 2017-09-30 | $301.71K 10-Q · filed 2017-10-23 |
| 2017-06-30 | $300.41K 10-Q · filed 2017-07-26 |
| 2017-03-31 | $158.14K 10-Q · filed 2017-04-26 |
| 2016-12-31 | $367.27K 10-K · filed 2018-02-13 |
| 2016-09-30 | $265.58K 10-Q · filed 2016-10-25 |
| 2016-06-30 | $209.72K 10-Q · filed 2016-07-26 |
| 2016-03-31 | $77.12K 10-Q · filed 2016-04-27 |
| 2015-12-31 | $170.79K 10-K · filed 2017-02-14 |
| 2015-09-30 | $354.70K 10-Q · filed 2015-10-29 |
| 2015-06-30 | $177.56K 10-Q · filed 2015-07-30 |
| 2015-03-31 | $110.38K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $461.97K 10-K · filed 2016-02-25 |
| 2014-09-30 | $317.69K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $38.03K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $153.87K 10-Q · filed 2014-05-08 |
| 2013-12-31 | $33.89K 10-K · filed 2015-03-12 |
| 2013-09-30 | $186.89K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $130.82K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $269.86K 10-Q · filed 2013-05-08 |
| 2012-12-31 | $491.85K 10-K · filed 2014-03-27 |
| 2012-09-30 | $333.00K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $440.11K 10-Q · filed 2012-08-09 |
| 2012-03-31 | $309.42K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $718.88K 10-K · filed 2013-03-28 |
| 2011-09-30 | $1.08M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $329.34K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $1.10M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |